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Abstract
Molecular pathways underlying the activation of dendritic cells (DCs) in response to Herpes Simplex Virus type 1 (HSV-1) are
poorly understood. Removal of the HSV virion host shut-off (vhs) protein relieves a block to DC activation observed during
wild-type infection. In this study, we utilized a potent DC stimulatory HSV-1 recombinant virus lacking vhs as a tool to
investigate the mechanisms involved in the activation of DCs by HSV-1. We report that the release of pro-inflammatory
cytokines by conventional DC (cDC) during HSV-1 infection is triggered by both virus replication-dependent and replication-
independent pathways. Interestingly, while vhs is capable of inhibiting the release of cytokines during infection of human
and mouse cDCs, the secretion of cytokines by plasmacytoid DC (pDC) is not affected by vhs. These data prompted us to
postulate that infection of cDCs by HSV triggers a TLR independent pathway for cDC activation that is susceptible to
blockage by the vhs protein. Using cDCs isolated from mice deficient in both the TLR adaptor protein MyD88 and TLR3, we
show that HSV-1 and the vhs-deleted virus can activate cDCs independently of TLR signaling. In addition, virion-associated
vhs fails to block cDC activation in response to treatment with TLR agonists, but it efficiently blocked cDC activation
triggered by the paramyxoviruses Sendai Virus (SeV) and Newcastle Disease Virus (NDV). This block to SeV- and NDV-
induced activation of cDC resulted in elevated SeV and NDV viral gene expression indicating that infection with HSV-1
enhances the cell’s susceptibility to other pathogens through the action of vhs. Our results demonstrate for the first time
that a viral protein contained in the tegument of HSV-1 can block the induction of DC activation by TLR-independent
pathways of viral recognition.
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Introduction
Herpes simplex virus (HSV) is a highly efficient pathogen
that infects between 60 and 80% of the US population [1]. An
important aspect of this pathogen’s success is the ability to suppress
or evade the host immune response at multiple stages of the
infection. Early in a primary infection, HSV-infected epithelial
cells are shielded from the host immune system long enough to
produce progeny virions that infect nearby sensory neurons
(reviewed in [2]). The virus enters a latent state in these neurons in
which limited gene expression occurs. Although the host immune
response eventually overcomes the viral immune suppressive
activities and clears the HSV infected epithelial cells, it is unable to
remove latent viral genomes from the neuronal tissues. The host
immune response against HSV greatly impacts the severity of
primary lesions [3,4,5] and is likely involved in the frequency of
reactivation [6,7].
Upon infection of the epithelial tissues, HSV encounters a
specialized type of immune cell, the dendritic cell (DCs). These
cells are the most potent antigen presenting cells known [8]. In an
uninfected individual, DCs reside within the epithelial tissue and
circulate in the blood stream in an immature state. Upon proper
stimulation, they undergo a process referred to as maturation
characterized by increased pro-inflammatory cytokine secretion
and expression of certain surface markers, e.g., CD80 and CD86
[9]. Concurrent with this maturation event, the DCs migrate into
lymph nodes where they can present antigen and stimulate T-cells.
HSV has been shown to infect and replicate to low levels within
immature [10] but not mature DCs [11,12]. Moreover, HSV-
infected DCs show a decrease in surface molecule expression and
cytokine release upon stimulation leading to a reduced ability
to stimulate allogeneic T-cell proliferation [10,13,14,15]. The
mechanism(s) underlying the suppression of DC activation by
HSV have not been deciphered. Identification of the viral genes
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e8684involved in suppressing DC maturation is an active area of
research that has implications for vaccine design and anti-HSV
immunotherapy.
Pathogen recognition by innate immune cells of the host is
a critical first step for the generation of an effective immune
response. The cellular pattern recognition receptors (PRRs)
necessary for the response to HSV vary based on cell type and
tissue localization. TLR9 signaling has been shown to be
responsible for splenic pDC activation in response to HSV-1
infection [16]. Recognition of a virion component at the cell
surface can activate signaling through TLR2 in microglial cells
[17]. Additionally, TLR2 is important for cytokine release in
certain cell systems and as such is a determinant for herpes
encephalitis [18]. A role for RIG-I in cooperation with TLR9 in
the recognition of HSV-2 has also been shown for fibroblast and
macrophage cell lines [19]. Further, TLR3 is critical for protection
against severe herpes infections and implicated as a target of viral
anti-apoptotic genes during human monocytic cell infections
[20,21]. An additional level of complexity is added by the fact that
a minor sub-population of virus within certain wild-type HSV-1
KOS viral stocks has been reported to utilize both TLR2 and
TLR9 to activate cDCs [22].
The virion host shutoff (vhs) protein of HSV is an RNAse,
which is known to preferentially degrade mRNA species
[23,24,25,26,27]. It is encoded by the UL41 gene, and is
synthesized late in infection (after genome replication) [28]. Vhs
is also present in the tegument and thus immediately functional
following virion uncoating [23,24,25]. The nuclease function of
the de novo synthesized vhs is thought to be partially compromised
as a result of its association with another viral protein, VP16
[29,30]. One earlier study showed that vhs blocks DC maturation.
In this report, the authors found that DCs non-productively
infected with a virus simultaneously lacking the ICP4, ICP27,
c34.5, VP16, and vhs genes displayed higher levels of cytokine
secretion and T-cell stimulation ability than a similar virus mutant
containing wild type vhs [31].
Here we directly determined the role of the vhs protein present
in the virus tegument on DC maturation in the context of a
productive HSV-1 infection using a recombinant HSV-1 virus
deficient in only vhs. In addition, the vhs deficient virus was used
as a tool to identify molecular pathways involved in the triggering
of DC maturation by HSV. Our data suggests that vhs functions
primarily to prevent DC activation by a TLR independent
pathway of virus recognition.
Materials and Methods
Viruses and TLR Agonists
KOS 1.1, referred to in this study as KOS, was the wild-type
strain of HSV-1 used in all experiments. The vhs mutant, Dsma,
referred to in this study as vhs
2, was generously provided by G.
Sullivan Read and has been previously described [27]. It contains
a deletion of the 588 basepair region between SmaI restriction
enzyme sites in the UL41 gene. HSV-GFP was generously
provided by Dr. D. Leib and contains the insertion of GFP
between UL49 and UL50 of the parental KOS strain. All viruses
were propagated and quantified on Vero cells as previously
described [32,33]. For experiments requiring UV inactivated
viruses, viral stocks were exposed to UV irradiation at 10 cm from
a germicidal lamp (UVP Multiple-Ray 8-WUV lamp [60 Hz];
Fisher) for 4 minutes. This amount of UV irradiation has
previously been shown to prevent viral transcription and
replication without inactivating the function of a representative
tegument protein, VP16 [34]. To confirm UV inactivation in the
present study, transcript levels for viral immediate early gene
products and RL2 (ICP0) were shown to be absent compared to
non-UV inactivated stocks via qRT-PCR (Fig. 1b). Further, no
virus growth was observed during Vero cell plaque assay.
Recombinant Newcastle Disease virus (NDV) B1 was generated
from B1 Hitchner avian vaccine strain as previously described
[35]. Sendai Virus (Cantel strain) was grown in 10-day old
embryonated eggs as previously described [36]. pI:C was obtained
from Amersham Biosciences and utilized at a concentration of
250 mg/mL. CpG was obtained from Coley Pharmaceutical
Group and utilizied at a concentration of 6 mg/mL. LPS was
obtained from Alexis Biochemicals and utilized at a concentration
of 300 ng/mL.
Mice
Wild-type C57/B6 mice were obtained from Taconic Farms.
MyD882/2 were kindly provided by Dr. S. Akira (Osaka
University, Osaka, Japan) and Dr. R. Steinman (Rockefeller
University, New York, NY). TLR32/2 mice were obtained from
Dr. R. Flavell (Yale University, New Heaven, CT). MyD88/TLR3
double knockout mice were obtained by crossing single knockouts
until homozygous for both genes. All mice were bred and
maintained in our facility consistent with regulations of animal
care standard protocol as described by the Mount Sinai School of
Medicine IACUC committee.
Cells
Vero cells. Vero cells were grown in tissue culture medium
(Dulbecco’s modified Eagles medium [Mediatech]) with 10% fetal
calf serum [Hyclone], 50 mg/ml gentamycin [Invitrogen]. All cells
were grown at 37uC at 5–7% CO2.
Human monocyte-derived conventional dendritic cells
(hu-cDCs) were cultured from peripheral blood monocytes as
previously described [37]. Briefly, cells were isolated by Ficoll
density gradient separation from Buffy coats (30–60 ml each) of
healthy human donors (Mount Sinai Blood Center and New York
Blood Center). CD14+ monocytes were isolated using magnetic
bead separation with anti-CD14 antibody-labeled magnetic beads
and iron-based MidimacsLS colums (MiltenyiBiotec). Cells were
cultured for 5–6 days in RPMI containing 10% fetal bovine serum
(FBS), 100 U/ml penicillin, 100 mg/ml streptomycin, 500 U/l
human granulocyte-macrophage colony-stimulating factor
(GMCSF), and 1,000 U/ml human interleukin-4 at 10
6 per ml
prior to infection.
Human plasmacytoid dendritic cells (hu-pDCs) were
directly isolated from the peripheral blood mononuclear cell
(PBMC) fraction after Ficoll density separation of Buffy coats using
BDCA4 (CD304)+ antibody labeled magnetic beads and elution
through iron-based MidimacsLS columns (MIltenyi Biotec).
Sample purity was assessed using Flow Cytometry. Briefly,
BDCA4+ cells were stained with FITC-CD123 and PE-BDCA2
(CD303), as per manufacturer’s instructions. Marker expression
was measured using the FC500 flow cytometer from Beckman
Coulter; data analysis was conducted using Flowjo software. Purity
was greater than 95%.
Human naı ¨ve CD4+ T-cells were directly isolated via
negative selection from the PBMC using an antibody cocktail
(Miltenyi Biotec) that contained biotin-conjugated CD8, CD14,
CD16, CD19, CD36, CD45RO, CD56, CD123, TCRc/d, and
Glycophorin A. Cells were further purified to remove HLA-DR+
cells using anti-HLA-DR microbeads (Miltenyi Biotec). Isolations
were conducted using iron-based MidimacsLS columns (MIltenyi
Biotec).
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by antibody depletion of all non-CD8+ cells followed by elution
through iron-based MidimacsLS columns (MIltenyi Biotec).
Murine-derived dendritic cells (mu-cDCs) were cultured
from bone marrow derived monocytes as previously reported [38].
Briefly, bone marrow was extracted from mouse femurs and tibias.
Red blood cells were lysed with ammonium chloride buffer. MHC
class II-expressing cells and lymphocytes were removed using a
cocktail of antibodies and magnetic bead separation. Purified
monocytes were cultured in 24 well dishes in RPMI medium
containing 10% FBS, 50 mg/ml gentamycin, 2 mM glutamine,
1 mM Na Py, and 50 U/ml recombinant granulocyte macro-
phage-colony-stimulating factor (PreproTech EC) at 1610
6
cells/ml.
Murine-derived plasmacytoid dendritic cells (mu-
pDCs) were prepared by Flt3-treatment of mouse bone marrow
Figure 1. HSV-1 productively infects and replicates in human cDCs. (a.) Human monocyte-derived conventional dendritic cells (hu-cDCs)
were infected with wild type HSV-1[KOS 1.1] (KOS) or the vhs-deficient virus, vhs-Dsma (vhs-), at an MOI of 5. Media of infected cultures was collected
at various times post infection and assayed for infectious virions using a vero cell plaque assay. The mean and standard deviation of triplicate assays
are plotted. (b.) qRT-PCR looking at mRNA levels of the immediate early viral gene RL2 at 6 hpi and 18 hpi. For UV-treatments, virus stocks were
exposed to UV light at a distance of 10 cm for 4 minutes. Both live and UV-treated viruses were used to infect cDCs at an MOI of 5. SeV-C infection
was performed at an MOI of 1.5. Data is represented as relative expression to normalized housekeeping gene levels. (c.) The ratio of the relative copy
numbers for a series of HSV-1 viral genes (KOS/vhs-) was determined for hu-cDCs at 6 hpi and 18 hpi.
doi:10.1371/journal.pone.0008684.g001
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100 ng/mL. Cells were cultured for 10 days at 37uC; media was
replaced containing Flt3 on day 5. Cells were sorted and enriched
for CD11b-, B220+ cells on day 10.
Multiplex ELISA
Cells and debris were removed from media of infected cells by
centrifugation (1000 x g, 5 minutes). Between 25 and 50 ml of this
cleared supernatant was subjected to multiplex ELISA procedure
for human IL-2, human IL-4, human IL-5, human IP-10 as per
manufacturer’s (Upstate) instructions. Briefly, the supernatants
were mixed with a combination of antibody-coated beads with
specific fluorescence properties. After appropriate washing, the
beads were mixed with PE-conjugated antibodies that will bind to
the cytokine of interest. A final set of washes was completed and
the fluorescent properties of each sample and appropriate
standards were measured using a Luminex plate reader. The data
was analyzed using software from Applied Cytometry Systems.
Capture ELISAs
ELISA kits for human TNF-a and human and mouse IL-6 (DuoSet
ELISA development systems) were obtained from R&D Systems.
ELISA kits for human IL-12p70 and human IFN-c were obtained
from eBiosciences. ELISAs for mouse IL-12p40 were conducted using
capture and secondary antibodies from BD Pharmingen. Manufac-
turer instructions were followed for all ELISA methods used. Plates
were read on an ELISA reader from Bioteck Instruments.
Flow Cytometry and Antibodies
Mouse monoclonal antibodies against both HSV-1 VP5 and b-
actin were obtained from Santa Cruz. PE-conjugated CD86 and
FITC-conjugated CD80 were obtained from Beckman Coulter and
BD Pharminigen, respectively. Cells were stained with antibodies
and subject to flow cytometry using the FC500 flow cytometer from
Beckman Coulter Data was analyzed with Flowjo software.
Quantitative RT-PCR (qRT-PCR)
RNA isolation was conducted on infected and non-infected cell
cultures at the indicated time-points using the commercially
available Absolutely RNA Microprep Kit from Stratagene. RNA
was concentrated via precipitation with ammonium acetate. An
equal amount of RNA was reverse transcribed to generate the
cDNA template to be used in qRT-PCR reactions using oligodT
(Roche) and Affinity Script Reverse Transcriptase (Stratagene).
cDNA was diluted 50-fold in water. PCR reactions were con-
ducted in triplicate using specific primers, Platinum Taq Poly-
merase (Roche), and SYBR green (Roche). Primer sequences are
shown in Table 1. Reactions were run on 384 well plates using the
Roche Lightcycler; normalizations were conducted using the levels
of the housekeeping genes b-Actin, a-Tubulin, and rps11.
Statistical Analysis
Statistical analysis was performed using t test, paired two sample
analysis.
Results
HSV-1 Activates cDCs through Replication-Dependent
and -Independent Pathways Both of Which Are Inhibited
by vhs
HSV-1 viruses carrying mutations in the gene encoding the vhs
protein, UL41, display a relatively minor reduction in the ability to
Table 1. Primer Sequences.
Gene Sense Sequence (59 R39) Anti-sense Sequence (59 R39)
HSV-1 RL2 (ICP0) GTGGTCGCCCTGTCGCGTTA GTCGCCATGTTTCCCGTCTG
HSV-1 UL54 (ICP27) CCCTTTCTCCAGTGCTACCT CTCTCCGACCCCGACACCAA
HSV-1 UL30 (Pol) CGAGTGCGAAAAGACGTTCA TGGAGGTGCGGTTGATAAAC
HSV-1 UL27 (gB) CTGCGAAACGGTGACGTCTT GCCCGAGGGTCAGAACTACA
HSV-1 UL44 (gC) TCCACCCTGCCCATTTCGTA GCGAGAACCCCGATTCCAAT
HSV-1 UL49 (VP22) GGTATGGCGAGTCCCGATAG GTTCGTCGTCTTCGGATGAC
SeV NP TGCCCTGGAAGATGAGTTAG GCCTGTTGGTTTGTGGTAAG
NDV HN CAATGCTGAGACAATAGGTC GACAATGCTTGATGGTGAAC
Hu-IFN-b GCCAGCGTCTGACGTTATGA GAGGGCTGATCCTACCACAA
Hu-IRF7 GGTGTGTCTTCCCTGGATAG GCTCCAGCTCCATAAGGAAG
Hu-IFN-c Receptor 2 ACCCTCCAGAGTGTACTGTT AGCACCGACAGCAACGAAAA
Hu-IL-12 Receptor B ACTGGAGCCTCAGCACATCT AGAGCATGAGGGAGTCACAC
Hu-b-actin ACTGGAACGGTGAAGGTGAC GTGGACTTGGGAGAGGACTG
Hu-a-tubulin GCCTGGACCACAAGTTTGAC TGAAATTCTGGGAGCATGAC
Hu-rps11 GCCGAGACTATCTGCACTAC ATGTCCAGCCTCAGAACTTC
Mu-IFN-b AGATGTCCTCAACTGCTCTC AGATTCACTACCAGTCCCAG
Mu-IFN-a TCCTGAGCCAAAGTGTAGAG GAGAACAAGTGCCTTTACAG
Mu-IL-6 ACAGAAGGAGTGGCTAAGGA CGCACTAGGTTTGCCGAGTA
Mu-IL-12p40 TTGAAAGGCTGGGTATCGGT GAATTTCTGTGTGGCACTGG
Mu-b-actin AGGTGACAGCATTGCTTCTG GCTGCCTCAACACCTCAAC
Mu-rps11 CGTGACGAAGATGAAGATGC GCACATTGAATCGCACAGTC
doi:10.1371/journal.pone.0008684.t001
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disruptions produce a much more dramatic growth defect in whole
animal models [40,41,42]. We first evaluated the capacity of a
recombinant vhs-deficient HSV virus (vhs
2) [27] to infect and
replicate in primary human monocyte-derived conventional DCs
(hu-cDCs). Control hu-cDCs were mock-infected or infected with
the HSV-1 wild type parent strain KOS. Virus released into the
media was quantified by plaque assay at different times post
infection (hpi) (Figure 1a). As expected, both HSV-1 and the vhs-
virus infected monocyte-derived hu-cDCs productively and
replicated to low levels, which is consistent with the work of
others [10]. Notably, there was an approximately 60-fold
difference between the amount of infectious virus released by
vhs–deleted and KOS-infected DCs at the 48 hour time-point.
The relative expression of the immediate early gene RL2 (ICP0)
was only modestly affected (2.2-fold) by the absence of vhs at 6 hpi
but it was significantly reduced (30-fold) by 18 hpi (Figure 1b). We
noted a similar difference for multiple HSV-1 genes over this time
course (Figure 1c). We further characterized the infection of hu-
cDCs by HSV-1 using an HSV-GFP virus (Figure S1a). At an
MOI of 5 (utilized in experiments throughout this study), we noted
GFP expression in the majority of cells. Additionally, as shown in
Figure S1b, quantitation of the major capsid protein VP5 was
similar for KOS, vhs-, and GFP infections showing that incoming
virus is similar for all different virus treatments utilized.
Consistent with a prior study using a highly mutated replication-
defective HSV virus, the induction of pro-inflammatory cytokines
(IL-6 and TNF-a) in response to HSV-1 was blocked by vhs
(Figures 2a and S3) [31]. Interestingly, the vhs protein inhibited
both the virus replication independent triggering of IL-6 and
TNF-a (UV inactivated virus) and the replication dependent
induction of IL-12, highlighting that the activation of cDCs in
response to HSV-1 occurs after sensing viral replication dependent
and independent events. The production of the chemokine IP-10
was not affected by vhs. A detailed kinetic analysis revealed that
the block to IL-6 and TNF-a production occurs as early as 6 hpi,
whereas IL-12 release is blocked by 12 hpi (Figure S2b). This
block to cytokine release is also observed at the level of mRNA
expression (Figure S2c). Lastly, we also observed elevated cell
surface expression of the co-stimulatory molecule CD86 in the vhs-
infected cultures at 24 hpi (Figure 2b).
Vhs Influences the Phenotype of T-Cells upon In Vitro
Allogeneic Co-Culture with Productively Infected cDCs
HSV-1 infection results in the polarization of CD4+ T-cells
towards a Th1 response characterized by the production of IFN-c
and IL-2 and the absence of Th2 cytokines such as IL-4 and IL-5
[43,44,45,46]. The capacity for hu-cDCs productively infected
with KOS or vhs-deficient viruses to stimulate T-cells was assessed
using an allogeneic co-culture assay. Both CD4+ and CD8+ T-
cells produced significantly more IFN-c upon co-culture with
cDCs infected with the vhs-deficient virus than with wild-type
KOS virus (Figure 2c). The decrease in IFN-c for KOS infection
in the CD8+ co-culture is consistent with HSV-1 actively blocking
allogeneic stimulation. In addition, CD4+ T-cell co-cultures
containing cDCs infected with the vhs- virus produced more IL-
2 than cultures with KOS infected cDCs (Figure 2d). IL-4 or IL-5
were not detected in these cultures. Analysis of gene expression by
RT-PCR revealed enhanced up-regulation of other genes
associated with a Th1 response when stimulated with vhs- infected
cDCs relative to KOS infected cDCs (Figure 2e). Taken together,
these data show that during a productive HSV-1 infection vhs
negatively regulates the development of Th1 immunity.
Vhs Does Not Block the Activation of Plasmacytoid DCs
Plasmacytoid DCs (pDCs) represent a class of DCs specialized
in the production of type I IFNs in response to virus infection [47].
To compare the effect of vhs during HSV-1 infection of pDCs to
that observed with cDCs, both cell types were prepared from the
same donor and infected with vhs- and KOS viruses. As shown in
Figure 3a, the vhs-mediated inhibition of IL-6 and TNF-a
production by cDCs is evident at 6 hpi. In contrast, vhs is unable
to alter the production of these cytokines by pDCs. Similar results
were also observed at the level of mRNA expression (Figure S4d).
There were no significant differences in measurements of
transcription of the IFN-b and IRF7 genes (an IFN-responsive
gene) following infection of pDCs with vhs- and KOS viruses.
We observed slightly less GFP expression following infection of
pDCs with HSV-GFP compared to cDCs (Figure S4a). Similarly,
we also detected less expression of the immediate early transcript
UL54 in comparing infections between the two cell types. (Figure
S4b). To ensure that the observed phenotypic difference between
cDCs and pDCs was not simply due to a less efficient infection of
the pDC, we increased the input of virus by 2- and 10-fold. As
shown in Figure S4c, even at high MOIs, there is no significant
difference in the cytokine response comparing infection of pDC
with wild type virus to the vhs-deficient virus. We conclude that
the negative regulatory role of vhs is functional in cDCs but not
pDCs.
HSV-1 Modulates Murine DC Activation Similar to Human
DC Activation
The pDC response to HSV-1 has been reported to occur in a
TLR9-dependent fashion [16,48]. In contrast, while cDCs express
TLRs, they have also been shown to respond to viral infection by
signaling through cytosolic pathways (RIG-I and mda5), which
recognize RNA molecules [47]. Also noteworthy is the recent
finding that a cytoplasmic DNA sensor is responsible for
recognition of DNA viruses and subsequent production of type I
IFN in vitro [49]. The failure of vhs to block the activation of pDCs
led us to speculate that inhibition of cDC cytokine release by vhs
may occur through a pathway independent of TLR signaling.
Due to the inherent difficulties in genetically manipulating
human systems in addressing mechanistic questions, we shifted our
study to a mouse bone marrow-derived DC system. As shown in
Figure 4, HSV-1 modulated the secretion of pro-inflammatory
cytokines and co-stimulatory molecules in murine DCs in a
manner similar to that of human DCs (Figure 2a, 2b and
Figure 3a). We also detected the expression of HSV-1 lytic
transcripts during infection mu-cDCs (data not shown).
HSV-1 Activation of mu-cDCs Does Not Depend on TLR
Signaling and Is Blocked by the vhs Protein
To evaluate the role of TLR signaling during HSV-1 infection
of cDCs, we first infected mu-cDCs isolated from double knock-
out mice deficient in both MyD88 and TLR3 with increasing
amounts of wild-type HSV-1 (KOS). As shown in Figure 5a, HSV-
1-infected mu-cDCs secreted pro-inflammatory cytokines (IL-6
and IL-12) and type I interferons (IFN-a and IFN-b) indepen-
dently of TLR signaling and in a dose-dependent manner. This
effect was also seen at the transcriptional level for KOS infection at
an MOI of 5.0 (Figure 5b).
Infection of mu-cDCs with the vhs-deficient virus triggered
significantly higher cytokine release than the KOS virus. This was
observed with mu-cDCs isolated from either control wild-type
mice, MyD88/TLR3 double knock-out, MyD88 single knock-out,
or TLR3 single knock-out mice showing that vhs can block the
Vhs Blocks a Non-TLR Pathway
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incapable of TLR signaling (Figure 6a). As a control, we infected
all mu-cDCs with Sendai virus, which our group has previously
shown to activate DCs independent of the TLR pathway [50].
Interestingly, upon comparing the secretion of IL-12 from the
three different knock-out conditions during vhs- infection it was
Figure 2. Virion-associated vhs blocks the activation of cDCs and can influence the phenotype of CD4+ T-cells during allogeneic in
vitro co-culture. (a.) hu-cDCs were infected with infectious (live) and UV inactivated KOS or vhs- at an MOI of 5. At 24 hpi, media from cultures were
collected and assayed for secreted IL-6, IL-12p70, and IP-10 using multiplex ELISA. Error bars represent the difference between duplicate assays. (b.)
hu-cDCs were infected with KOS and vhs- viruses at an MOI of 5; at 24 hpi, cells were harvested, and cell surface expression of hu-CD86 was measured
by Flow Cytometry. (c.) hu-cDCs were infected with KOS and vhs- viruses at an MOI of 5. After a 1-hour infection, virus was removed and the hu-cDCs
were co-cultured in a 1:5 ratio with either naı ¨ve CD4+ or CD8+ T-cells. At days 3, 4, and 5, cells were harvested and the supernatants were analyzed for
secreted IFN-c by ELISA. Error bars represent the difference between duplicate assays. ** denotes a p-value ,0.005. (d.) Co-cultures of cDCs and CD4+
T-cells were harvested at day 4 and assayed for secreted IL-2 (Th1 cytokine), IL-4 and IL-5 (Th2 cytokines) by Multiplex ELISA. * denotes a p-value
,0.05 (e). Co-cultures of cDCs and CD4+ T-cells were harvested at day 4. RNA was isolated from cell pellets and subject to qRT-PCR to analyze the
relative expression of Th1-associated genes relative to normalized housekeeping genes. * denotes a p-value ,0.05; ** denotes a p-value ,0.005.
doi:10.1371/journal.pone.0008684.g002
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response to the highly stimulatory vhs- virus. Figure 6b represents
the assay controls.
Vhs Blocks the Activation of hu-cDCs and mu-cDCs by
SeV and NDV, but Not by TLR Agonists
To expand on the findings using TLR knock-out mice we
infected human and mouse cDCs (Figure 7) with HSV-1 (either
KOS or vhs-) and immediately co-treated the cells with either
TLR agonists (pI:C, LPS, or CpG) or RIG-I/mda5 agonists (SeV
and NDV). While infection with vhs- virus resulted in the
production of cytokines in response to co-treatment with TLR
agonists or virus, infection with wild type virus resulted in impaired
production of cytokines in response to either SeV or NDV, but not
to TLR ligands. This capacity for vhs to block SeV and NDV
activation of the cDC was significant even in the absence of virus
replication at the 6 hpi time-point (Figure 7c).
These results indicate that vhs inhibits the TLR-independent
activation of DCs but not the TLR-dependent response. These
observations are consistent with both the inability of vhs to block
the TLR-dependent pDC response to HSV (Figure 3), as well as
the TLR-independent antagonistic nature of this protein (Figure 6).
Vhs Enhances the Ability of SeV and NDV to Replicate in
mu-cDCs
Based on the ability of vhs to block both SeV and NDV-induced
cytokine production in mu-cDCs, we hypothesized that expression
of viral genes specific to these viruses would be elevated during co-
infections with KOS compared to vhs-. As shown in Figure 8,
expression of the NP gene of SeV and the HN gene of NDV are
both elevated when co-infected with the vhs-containing wild-type
KOS relative to the vhs- co-infection for both live and UV
inactivated viruses. Thus, infection with HSV makes cells more
susceptible to other infectious agents through the action of the vhs
protein.
Discussion
Our results demonstrate that during a productive HSV-1
infection the vhs protein carried in the tegument can inhibit the
early innate immune response in both human and mouse
monocyte-derived cDCs. These data suggest that this protein,
released into infected cells at the time of infection, inhibits the
triggering of cDCs probably until other antagonistic proteins are
produced. HSV is capable of productively replicating in cDCs,
and its replicative capacity is improved by the presence of the
vhs protein (Figure 1). This observation is presumably due to a
synergism of 2 events: 1.) inefficient immediate early gene
expression in the absence of vhs (Figure 1b and 1c) and 2.)
elevated type I IFN found in vhs- infected cells (Figure 3b). A
previous report showed that infection of cDCs with a replication-
defective viral construct lacking vhs resulted in elevated levels of
pro-inflammatory cytokines at late time-points post infection
compared to the same viral construct containing vhs [31]. Since
we hypothesized that vhs functions early in infection we analyzed
the cellular response at early times points. We confirmed that there
was an enhanced release of IL-6 and TNF-a in dendritic cells in
response to UV-inactivated virus lacking vhs. Interestingly, IL-12
production by infected DCs was also susceptible to vhs inhibition
but was only produced in response to live virus. These data
indicate that cDC activation during HSV-1 infection is triggered
through both replication-dependent and replication-independent
pathways. In addition, experiments using T cell co-cultures
demonstrated that the vhs protein impaired the development of
Th1 immunity as shown by the impairment in the expression of a
Figure 3. Vhs does not block pDC cytokine secretion. (a.) Plasmacytoid DCs (hu-pDCs) were directly isolated from buffy coats and infected with
KOS and vhs- viruses at an MOI of 5. Hu-cDCs were cultured from monocytes isolated from the same buffy coats and infected similar to hu-pDCs. At
6 hpi, supernatants were analyzed for secreted TNF-a and IL-6 by ELISA. Error bars represent the difference between duplicate assays. (b.) RNA was
extracted from cell pellets at the 6 hour time-point, reverse-transcribed and subject to qRT-PCR for relative expression of IFN-b and IRF7 to
normalized housekeeping genes. * denotes a p-value ,0.05; ** denotes a p-value ,0.005.
doi:10.1371/journal.pone.0008684.g003
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PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e8684Figure 4. HSV-1 modulates the activation of murine-derived DCs similar to human-derived DCs. (a.) mu-cDCs were infected with both
live and UV inactivated virus stocks at an MOI of 5. At 12 hpi, cells were harvested, and the levels of IL-6 and IL-12p40 were measured in the
supernatants (ELISA). qRT-PCR was used to measure the mRNA levels of IP-10 within infected cells. Data is represented as relative expression relative
to levels of housekeeping genes. Error bars denote the difference between duplicate (ELISA) and triplicate (PCR) assays. (b.) mu-pDCs were infected
with KOS and vhs- viruses at an MOI of 5; released IL-6 and TNF-a were measured by ELISA assay at 6 hpi. (c.) mu-cDCs were infected with KOS and
vhs- viruses; cell surface expression of mu-CD80 was measured by Flow Cytometry at 24 hpi.
doi:10.1371/journal.pone.0008684.g004
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PLoS ONE | www.plosone.org 8 February 2010 | Volume 5 | Issue 2 | e8684Figure 5. DCs are activated in a TLR-independent manner during HSV-1 infection. (a.) mu-cDCs isolated from MyD88, TLR3 double knock-
out (DKO) and control C57BL/6 wild-type mice were infected with increasing amounts of wild-type HSV-1 (KOS). At 12 hpi, cells were harvested and
released IL-6, IL-12p40, IFN-a, and IFN-b were quantitated by ELISA. (b.) RNA was extracted from the cell pellets from the above experiment and
subject to qRT-PCR for the corresponding genes. Data is represented as relative expression relative to levels of housekeeping genes. CpG (6 ug/mL)
was utilized to control for and confirm MyD88 deficiency; pI:C (250 ug/mL) was utilized to control for and confirm TLR3 deficiency.
doi:10.1371/journal.pone.0008684.g005
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PLoS ONE | www.plosone.org 9 February 2010 | Volume 5 | Issue 2 | e8684Figure 6. Vhs blocks a TLR-independent pathway of DC activation during HSV-1 infection. (a.) mu-cDCs isolated from MyD88, TLR3
double knock-out (DKO), MyD88 KO, and TLR3 KO mice were infected with KOS, vhs-, and SeV at an MOI of 5 for HSV-1 and 1.5 for SeV. Mu-cDCs from
control C57BL/6 mice were isolated on three separate occasions and infected with virus. (b.) CpG (6 ug/mL) and pI:C (250 ug/mL) were used to
control for and confirm MyD88 and TLR3 deficiencies, respectively. IL-6 and IL-12p40 levels were measured in the supernatants of infected cultures at
12 hpi. For knock-out infections, error bars denote the difference between duplicate assays. For wild-type (C57BL/6) infections, error bars denote the
difference between 3 independent experiments. * denotes a p-value ,0.05; ** denotes a p-value ,0.005.
doi:10.1371/journal.pone.0008684.g006
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PLoS ONE | www.plosone.org 10 February 2010 | Volume 5 | Issue 2 | e8684Figure 7. Vhs fails to block the activation of DCs due to TLR agonists. (a.) hu-cDCs were infected with either SeV at an MOI of 1.5 or treated
with pI:C (250 ug/mL) for 6 hpi [black bars]; In parallel, hu-cDCs were infected with KOS and vhs- at an MOI of 5 and then immediately treated with
SeV or pI:C [gray bars]. At 6 hpi, released IL-6 and TNF-a were measured in the supernatants of cells. (b.) mu-cDCs were treated with LPS (300 ng/mL),
CpG (6 ug/mL), or infected with NDV (MOI of 1.5) for 6 hpi [black bars]; In parallel, mu-cDCs were infected with KOS and vhs- at an MOI of 5 and then
immediately treated with LPS, CpG, or NDV [gray bars]. At 6 hpi, released IL-6 was measured in the supernatants of cells. (c.) Same set-up as in (b.). IL-
12p40 was measured in the supernatants of cells at 6 hpi. (d. and e.) Identical set-up to (b and c.), this time infections were performed using UV-
inactivated HSV-1 virus stocks. Error bars denote the difference between duplicate assays. * denotes a p-value ,0.05; ** denotes a p-value ,0.005;
*** denotes a p-value ,0.0005.
doi:10.1371/journal.pone.0008684.g007
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PLoS ONE | www.plosone.org 11 February 2010 | Volume 5 | Issue 2 | e8684Figure 8. Higher expression of SeV and NDV specific genes during wild-type HSV-1 infection. RNA was extracted from the cell pellets of
mu-cDCs following co-infections/co-treatments with TLR agonists at 6 hpi. qRT-PCR was used to check expression levels for the following viral genes:
(a.) UL54 (HSV-1), (b. and d.) HN (NDV) and (c. and e.) NP (SeV). Data is represented as relative expression relative to levels of housekeeping genes.
Error bars denote the difference between triplicate assays.
doi:10.1371/journal.pone.0008684.g008
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PLoS ONE | www.plosone.org 12 February 2010 | Volume 5 | Issue 2 | e8684number of Th1-related genes. These results demonstrated a
critical role of the vhs protein in controlling the development of
both innate and adaptive immunity in response to HSV-1
infection.
An important observation derived from our studies is that the
viral vhs protein inhibits a TLR-independent pathway of cell
activation (Figure 6). A number of studies have shown that TLR9
is utilized in the recognition of HSV-1 by pDCs [16,48] while the
response to HSV-1 in cDCs is independent of TLR2, TLR9 and
MyD88 [16,51]. The role of TLR3 in the DC response to HSV is
not well established. We found that infection of mu-cDCs isolated
from mice double deficient in MyD88 and TLR3 with the KOS
strain of HSV-1 responded identically to mu-cDCs from wild-type
control mice (Figure 5a). Thus, cDCs are capable of responding to
the KOS 1.1 strain of HSV-1 in the absence of any of the TLRs
typically attributed to viral recognition (TLR2, 3, 7, 8, and 9). In
addition, vhs fails to block the secretion of IL-6 from LPS-treated
(TLR4 stimulated) mu-cDCs upon co-treatment with HSV-1
(Figure 7b and 7d) again suggesting that the vhs antagonism is
functional against a pathway not triggered through a TLR. The
inability of vhs to block LPS-stimulated DCs in our study is
in contrast to a previous report showing a repression of co-
stimulatory molecule up-regulation upon infection with a viral
construct containing vhs [31]. One potential explanation for this
difference is that the ability of vhs to antagonize NF-kB-dependent
genes (IL-6, TNF-a) may be separate from its ability to block IFN-
dependent events (co-stimulatory molecule up-regulation).
Interestingly, the secretion of IL-12 following infection with the
highly stimulatory vhs-deletion virus was enhanced when TLR3
was present (Figure 6a). Although we observed 10-fold higher
levels of IL-12 in the vhs- infections relative to KOS for cells
isolated from mice deficient in TLR3, we suspect that the
difference compared to infection of mu-cDCs from wild-type mice
and MyD88 single knock-out mice (where TLR3 is present and
functional) may be attributable to the function of vhs as a viral
nuclease (see below). During cDC infection with the highly
stimulatory vhs- virus, dsRNA molecules may accumulate due to a
failure of vhs to efficiently degrade viral replication intermediates
[52]. Such viral intermediates could potentially activate DCs
through TLR3 and enhance the signaling.
Our results are consistent with vhs blocking a viral sensing
pathway independent of TLRs. Despite observing elevated mRNA
expression of pro-inflammatory cytokines and type I IFN in the
vhs- infected cDC cultures (Figures S2c and 3), we failed to find
such differences in the co-treatment experiments when HSV-1
infected DCs were stimulated with TLR agonists (Figure 7). This
suggests that the target(s) of vhs is not these mRNA transcripts, but
rather at some point upstream of their expression. Specifically, the
activation step for both HSV-1 as well as the paramyxoviruses SeV
and NDV appear to be blocked by vhs. Both SeV and NDV
induced activation of hu- and mu-cDCs including pro-inflamma-
tory cytokine release. However, this activation was blocked when
the cells were co-infected with KOS. This is consistent with an
earlier report showing that HSV-1 blocked type I Interferon
production by SeV [53]. We further report here that removal of
vhs relieves this block to DC cytokine release observed during co-
infection with KOS and either SeV or NDV. DC activation due to
the paramyxoviruses SeV and NDV has been reported to occur by
signaling through the intracellular receptors RIG-I and mda5 and
to be dependent upon virus replication [54,55]. In addition, it has
been recently shown that RIG-I contributes to the recognition of
HSV-2 in macrophages [19]. Our results argue that vhs may
actively block signaling due to either RIG-I, mda5, or both.
Experiments to investigate what role these cytoplasmic sensors
play in the vhs-mediated inhibition of cytokines during HSV-1
infection are underway.
The observation that infection with one pathogen can enhance
the susceptibility to another, or alter its disease progression, has
been reported for multiple viruses [56,57,58]. Understanding
which viral factors are responsible for such observations may be
important for the optimal design of therapeutics and/or vaccines.
With respect to HSV, interest in vhs-deletion vaccine candidates
has previously been reported [59]. The presence of the vhs protein
fosters a cellular environment optimal for the replication of HSV-1
during a productive infection (Figure 1). If the promotion of viral
replication results from the inhibition of pro-inflammatory
cytokines and type I IFN by vhs in cDCs (Figures 2 and 3), then
HSV co-infection might create a milieu conducive to infection by
other viruses. We observed both a repression of cytokine release
(Figure 7) and an enhancement of their respective viral gene
expression (Figure 8) when SeV or NDV were co-infected with
KOS. We noted a similar result when UV-inactivated viruses were
utilized in these co-treatment experiments. However, while still
significant, there were elevated levels of both IL-6 and IL-12 when
SeV and NDV were co-infected with UV KOS (Figure 7d and e).
This suggests that the influence of vhs on the expression of other
HSV-1 genes (Figure 1c) may contribute to the strong inhibition
observed during live virus co-infections (Figure 7b and c). The data
presented here shows that the vhs protein is at least partially
responsible for this effect.
Vhs is a nuclease, which belongs to a family of endonucleases
that includes DNAse IV, ERCC-5, and yeast RAD2 [60,61,62]. It
acts to degrade cellular and viral mRNAs early in HSV infection.
Although vhs was originally thought to act globally to limit all gene
expression, recent reports have determined that some cellular
mRNA molecules are resistant to vhs activity during infection
[63,64]. Consistent with this data, our results indicated that the
levels of the chemokine IP-10 are not affected by vhs (Figure 2 and
4). Interestingly, when we compared the activity of vhs in cDCs to
MEFs (mouse embryo fibroblast cells), we observed that cDCs
appear to be more resistant to vhs as measured by Ct levels of
cellular housekeeping genes (Figure S5), again suggesting that the
effect of vhs is not simply global degradation. Other reports have
shown that neurons are less affected by the vhs protein [65,66].
This phenotype was shown to be dependent on the amount of
input virus [66]. An analysis of additional cell types, dose-response
experiments using our viruses, and other assays to assess vhs
activity are in progress. It is also possible that the inhibition of DC
maturation is occurring through an as yet unidentified function of
vhs. A recent report has shown that a portion of vhs is associated
with lipid rafts in cellular membranes [67]. The lipid-associated
vhs would be in the correct location to interact with cellular
molecules involved in signal transduction. Mutational analysis of
the vhs protein would allow us to determine whether the nuclease
function of vhs can be separated from its effect on DC activation.
HSV-1 primarily infects epithelial cells [2] and cDCs residing in
the epithelial tissue. The viral vhs protein may have evolved to
silence the pro-inflammatory response induced in these cells to
allow the replication of its genome and help secure its latent
phenotype in neurons. Our data demonstrate that vhs does not
influence the expression and secretion of pro-inflammatory
cytokines and type I IFN by pDCs. These cells do not reside in
epithelial tissues [68] and may not be exposed to the virus early in
the primary infection. Moreover, a recent study concludes that
cDCs are crucial for presentation to CD4
+ and CD8
+ T-cells but
pDCs are not involved in the activation of T-cells during HSV-1
infection [69]. Thus, the inhibition of cDC maturation (Figures 2a
and 3) but not pDCs and the enhanced ability of cDC infected
Vhs Blocks a Non-TLR Pathway
PLoS ONE | www.plosone.org 13 February 2010 | Volume 5 | Issue 2 | e8684with the vhs-deletion virus to stimulate T-cells (Figure 2b) would
seem to be correctly targeted to suppress T cell activation.
In summary, the results of these studies have demonstrated that
vhs carried in the tegument is a potent early antagonist of DC
activation during a productive HSV-1 infection. Further, vhs
blocks a pathway to cytokine release in cDCs that is independent
of TLR signaling. These insights into DC function during infection
may be valuable to herpes-based vaccine development and gene
therapy research.
Supporting Information
Figure S1 (a.) GFP expression in hu-cDCs. Hu-cDCs were
infected with HSV-GFP at an MOI of 5. At 18 hpi, cells were
harvested and GFP was measured by Flow Cytometry; analysis
was performed using Flowjo. (b and c.) Incoming VP5 expression.
Hu-cDCs were infected with KOS, vhs-, and HSV-GFP at an
MOI of 5. At 3 hpi, cells were harvested, fixed in 0.5% PFA,
permeabilized in 0.1% Saponin, and stained for intracellular
expression of the major HSV-1 capsid protein VP5. Measurement
of internalized VP5 was performed using Flow Cytometry; analysis
was conducted using Flowjo. A graphical representation is shown
in (c.)
Found at: doi:10.1371/journal.pone.0008684.s001 (1.03 MB
PDF)
Figure S2 (a.) Mock Vero Cell Lysate does not activate hu-
cDCs. Hu-cDCs were infected with KOS and vhs- virus at an
MOI of 5. Mock Vero lysate and New Castle Disease Virus (NDV)
infections were used as controls. At 18 hpi, the media from the
cultures was collected and assayed for secreted IL-6 and TNF-I ˆ6
using multiplex ELISA. Error bars represent the difference
between duplicate assays. (b.) Vhs blocks the activation of cDCs
by 6 hpi for IL-6 and TNF-I ˆ6; by 12 hpi for IL-12p70. Hu-cDCs
were infected with KOS and vhs- viruses at MOIs of 0.5 or 5.
Media was collected at various times post infection and analyzed
for the presence of secreted IL-6, TNF-I ˆ6, IL-12p70, and IP-10
using multiplex ELISA. Error bars represent the difference
between duplicate assays. (c.) Higher mRNA expression of pro-
inflammatory cyokines in vhs- infected hu-cDC cultures. Hu-cDCs
were infected with KOS and vhs- viruses at an MOI of 5. At 6 and
12 hpi, cells were harvested; RNA isolated and subject to qRT-
PCR looking at the relative expression of IL-6, TNF-I ˆ6, and IL-
12p40.
Found at: doi:10.1371/journal.pone.0008684.s002 (2.89 MB
PDF)
Figure S3 Stocks of KOS and vhs- virus were exposed to UV
irradiation and used to infect hu-cDCs at volumes equivalent to
MOIs of 0.05, 0.5, and 5. At 24 hpi, media from cultures were
collected and analyzed for secreted TNF-I ˆ6 and IL-6 using
multiplex ELISA. Error bars represent the difference between
duplicate assays.
Found at: doi:10.1371/journal.pone.0008684.s003 (0.16 MB
PDF)
Figure S4 (a) GFP expression in hu-pDCs. Hu-pDCs were
infected with HSV-GFP, harvested at 12 hpi, and subject to Flow
Cytometry to measure GFP expression; analysis was performed
using Flowjo. (b.) Comparing HSV-1 gene expression in hu-cDCs
to hu-pDCs. Monocyte-derived human dendritic cells (hu-cDCs)
and plasmacytoid dendritic cells (hu-pDCs) isolated from the same
donor were infected with HSV-1 at an MOI of 5. At 6 hpi, cells
were harvested, RNA isolated and subject to qRT-PCR looking at
the relative expression of the HSV-1 viral gene UL54. Error bars
represent the difference between triplicate assays. (c.) Dose-
response HSV-1 infection of hu-pDCs. Hu-pDCs were infected
with KOS and vhs- viruses at MOIs of 10 and 50; Cells were
harvested at 6 hpi and subject to ELISA assay for released IL-6
and TNF-I ˆ6. Error bars represent the difference between
duplicate assays. (d.) Pro-inflammatory cytokine mRNA levels
are negatively regulated by vhs in cDCs, but not in pDCs. Same as
in (b.), qRT-PCR was used to measure relative gene expression of
IL-6, TNF-I ˆ6, and IL-12p40. Error bars represent the difference
between triplicate assays.
Found at: doi:10.1371/journal.pone.0008684.s004 (1.06 MB
PDF)
Figure S5 Hu-cDCs and Mouse Embryo Fibroblast (MEF) cells
were infected with KOS and vhs- viruses at an MOI of 5. At
18 hpi, cells were harvested, RNA was isolated and subjected
qRT-PCR. Levels of the housekeeping genes rps11 and b-actin
were measured. Data shown is a representative from multiple
experiments and presented as median Ct value. Error bars
represent the difference between triplicate assays.
Found at: doi:10.1371/journal.pone.0008684.s005 (1.00 MB
PDF)
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